Available from: Boer J, Jemec GBE
No published clinical studies were identified demonstrating appetite, metabolism, or weight-loss effects from transdermal herbal patches of this type
Licensed UK weight management medicines include semaglutide 2.4 mg (Wegovy) under NICE TA875
Sugar, fat, ultra-processed foods, and alcohol engage overlapping gutbrain pathways
In the STEP 1 trial extension, participants who discontinued semaglutide regained two-thirds of their prior weight loss within one year
doi:10.2174/157015909787602788 Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, Eraksoy M, Meluzinova E, Rektor I, Dawson KT, Sandrock AW, ONeil GN, BG-12 Phase IIb Study Investigators (2008) Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study